KemPharm, Inc. - Special Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the AZSTARYS FDA Approval Conference Call. (Operator Instructions)
I would now like to turn the call over to your host, Mr. Jason Rando of Tiberend Strategic Advisors. Sir, you may begin.
Good morning, and thank you for joining today's call to discuss the FDA approval of AZSTARYS, formerly KP415.
Before we begin, I would like to remind our listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties and are subject to changes at any time including, but not limited to, statements about KemPharm's expectations regarding future operating results.
Forward-looking statements are made pursuant to the safe harbor provisions of the federal securities laws and represent management's current expectations. Actual results may differ materially. KemPharm disclaims any obligation to update or revise its forward-looking statements, except as required by law. More
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
